These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

61 related items for PubMed ID: 7251816

  • 1. Dopaminergic regulation of growth hormone (GH) secretion in normal man: correlation of L-dopa and dopamine levels with the GH response.
    Bansal S, Lee LA, Woolf PD.
    J Clin Endocrinol Metab; 1981 Aug; 53(2):301-6. PubMed ID: 7251816
    [No Abstract] [Full Text] [Related]

  • 2. Carbidopa inhibits the growth hormone- and prolactin-suppressive effect of L-dopa in acromegalic patients.
    Camanni F, Picotti GB, Massara F, Molinatti GM, Mantegazza P, Müller EE.
    J Clin Endocrinol Metab; 1978 Sep; 47(3):647-52. PubMed ID: 263317
    [Abstract] [Full Text] [Related]

  • 3. In vitro effect of dopamine and L-dopa on prolactin and growth hormone release from human pituitary adenomas.
    Peillon F, Cesselin F, Bression D, Zygelman N, Brandi AM, Nousbaum A, Mauborgne A.
    J Clin Endocrinol Metab; 1979 Nov; 49(5):737-41. PubMed ID: 489713
    [Abstract] [Full Text] [Related]

  • 4. Cholinergic receptor control mechanisms for L-dopa, apomorphine, and clonidine-induced growth hormone secretion in man.
    Delitala G, Maioli M, Pacifico A, Brianda S, Palermo M, Mannelli M.
    J Clin Endocrinol Metab; 1983 Dec; 57(6):1145-9. PubMed ID: 6688812
    [Abstract] [Full Text] [Related]

  • 5. Effect of dopamine agonist (Lergotrile mesylate) therapy on twenty-four hour secretion of prolactin in treated Parkinson's disease.
    Bell RD, Carruth A, Rosenberg RN, Boyar RM.
    J Clin Endocrinol Metab; 1978 Oct; 47(4):807-11. PubMed ID: 45469
    [Abstract] [Full Text] [Related]

  • 6. Dynamic tests of prolactin secretion in hyperprolactinemic states: carbidopa-L-dopa and indirectly acting dopamine agonists.
    Genazzani AR, De Leo V, Murru S, Cocchi D, Camanni F, Müller EE.
    J Clin Endocrinol Metab; 1982 Feb; 54(2):429-35. PubMed ID: 7054227
    [No Abstract] [Full Text] [Related]

  • 7. Surgical cure of prolactinoma reverses abnormal prolactin repsonse to carbidopa/L-dopa.
    Molitch ME, Goodman RH, Post KD, Biller BJ, Moses AC, King LW, Feldman ZT, Reichlin S.
    J Clin Endocrinol Metab; 1982 Dec; 55(6):1118-23. PubMed ID: 7130339
    [Abstract] [Full Text] [Related]

  • 8. Dopamine inhibition of stimulated growth hormone secretion: evidence for dopaminergic modulation of insulin- and L-dopa-induced growth hormone secretion in man.
    Woolf PD, Lantigua R, Lee LA.
    J Clin Endocrinol Metab; 1979 Sep; 49(3):326-30. PubMed ID: 468965
    [No Abstract] [Full Text] [Related]

  • 9. [Stimulation of growth hormone (STH) in the outpatient clinic using L-Dopa plus carbidopa and physical loading].
    Amendt P, Rohde W.
    Kinderarztl Prax; 1979 Jul; 47(7):362-7. PubMed ID: 480794
    [No Abstract] [Full Text] [Related]

  • 10. Preservation of dopaminergic and alpha-adrenergic function in children with growth hormone neurosecretory dysfunction.
    Bercu BB, Root AW, Shulman DI.
    J Clin Endocrinol Metab; 1986 Oct; 63(4):968-73. PubMed ID: 3018032
    [Abstract] [Full Text] [Related]

  • 11. [Effect of carbidopa and L-dopa combination on the secretion of growth hormone in normal subjects and in patients with Parkinsonism].
    Nurzia A, Vacca U, Pirro R, Cerone G.
    Clin Ter; 1975 Aug 15; 74(3):265-70. PubMed ID: 1227747
    [No Abstract] [Full Text] [Related]

  • 12. The effects of l-DOPA and sulpiride on growth hormone secretion at different injection times in Holstein steers.
    Kasuya E, Sutoh M, Yayou KI.
    Anim Sci J; 2017 Nov 15; 88(11):1842-1848. PubMed ID: 28585780
    [Abstract] [Full Text] [Related]

  • 13. Failure of papaverine to alter L-dopa-influenced GH and PRL secretion.
    Cooper DS, Jacobs LS.
    J Clin Endocrinol Metab; 1977 Mar 15; 44(3):585-7. PubMed ID: 838852
    [Abstract] [Full Text] [Related]

  • 14. Loss of central nervous system component of dopaminergic inhibition of prolactin secretion in patients with prolactin-secreting pituitary tumors.
    Fine SA, Frohman LA.
    J Clin Invest; 1978 Apr 15; 61(4):973-80. PubMed ID: 659585
    [Abstract] [Full Text] [Related]

  • 15. Dissociation of growth hormone and prolactin response to levodopa during pyridoxine administration.
    Delitala G, Masala A.
    Biomedicine; 1977 Jul 15; 27(6):219-22. PubMed ID: 20170
    [Abstract] [Full Text] [Related]

  • 16. Effects of CNS dopamine augmentation on stimulated prolactin secretion.
    Woolf PD, Leebaw WJ, Lee LA.
    J Clin Endocrinol Metab; 1977 Oct 15; 45(4):857-60. PubMed ID: 410827
    [Abstract] [Full Text] [Related]

  • 17. Effect of central nervous system dopaminergic activation on prolactin secretion in man: evidence for a common central defect in hyperprolactinemic patients with and without radiological signs of pituitary tumors.
    Crosignani PG, Ferrari C, Malinverni A, Barbieri C, Mattei AM, Caldara R, Rocchetti M.
    J Clin Endocrinol Metab; 1980 Nov 15; 51(5):1068-73. PubMed ID: 7419682
    [No Abstract] [Full Text] [Related]

  • 18. L-dopa absorption and the pituitary-hypothalamic axis.
    Boyd AE, Angoff G, Long A, Mager M.
    J Clin Endocrinol Metab; 1978 Dec 15; 47(6):1341-7. PubMed ID: 263355
    [Abstract] [Full Text] [Related]

  • 19. Abnormal growth hormone responsiveness to stimuli in women with active celiac sprue.
    Peracchi M, Molteni N, Cantalamessa L, Bardella MT, Peracchi G, Orsatti A, Faggioli P, Bianchi PA.
    Am J Gastroenterol; 1992 May 15; 87(5):580-3. PubMed ID: 1595643
    [Abstract] [Full Text] [Related]

  • 20. Effects of dexamethasone on growth hormone (GH)-releasing hormone, arginine- and dopaminergic stimulated GH secretion, and total plasma insulin-like growth factor-I concentrations in normal male volunteers.
    Miell JP, Corder R, Pralong FP, Gaillard RC.
    J Clin Endocrinol Metab; 1991 Mar 15; 72(3):675-81. PubMed ID: 1671785
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.